ABNORMAL ENDOTHELIAL RELEASE OF FIBRINOLYTIC-ACTIVITY AND FIBRONECTIN IN DIABETIC MICROANGIOPATHY

被引：35

作者：

HAITAS, B

BARNES, AJ

CEDERHOLMWILLIAMS, SA

MOORE, J

SHOGRY, MEC

TURNER, RC

机构：

[1] RADCLIFFE INFIRM,DIABET RES LABS,WOODSTOCK RD,OXFORD OX2 6HE,ENGLAND

[2] JOHN RADCLIFFE HOSP,DEPT HAEMATOL,OXFORD OX3 9DU,ENGLAND

来源：

DIABETOLOGIA | 1984年 / 27卷 / 05期

关键词：

D O I：

10.1007/BF00290382

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：493 / 496

页数：4

共 31 条

[1] DIABETIC-RETINOPATHY AND FIBRINOLYTIC SYSTEM [J].

ALMER, LO ;

PANDOLFI, M ;

NILSSON, IM .

DIABETES, 1975, 24 (06) :529-534

[2]

ALMER LO, 1981, THROMB RES, V20, P231

[3] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].

ASTRUP, T ;

MULLERTZ, S .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351

[4] PLATELET HYPERAGGREGATION AND INCREASED PLASMA-LEVEL OF VONWILLEBRAND FACTOR IN DIABETICS WITH RETINOPATHY [J].

BENSOUSSAN, D ;

LEVYTOLEDANO, S ;

PASSA, P ;

CAEN, J ;

CANIVET, J .

DIABETOLOGIA, 1975, 11 (04) :307-312

[5] CHANGES OF FIBRINOLYSIS AND FACTOR-VIII COAGULANT, ANTIGEN, AND RISTOCETIN COFACTOR IN DIABETES-MELLITUS AND ATHEROSCLEROSIS [J].

BERN, MM ;

CASSANI, MP ;

HORTON, J ;

RAND, L ;

DAVIS, G .

THROMBOSIS RESEARCH, 1980, 19 (06) :831-839

[6]

BLOOM AL, 1979, MEDICOGRAPHIA, V1, P3

[7] EFFECT OF VENOUS OCCLUSION ON ANTITHROMBIN-III, PLASMINOGEN ACTIVATOR AND FIBRINOGEN DEGRADATION PRODUCT (FRAGMENT-E) LEVELS [J].

CHAN, TK ;

CHAN, V .

THROMBOSIS RESEARCH, 1979, 14 (4-5) :525-534

[8]

CHLMIELEWSKA J, 1983, THROMBOSIS RES, V31, P427

[9] FIBRONECTIN IS PRODUCED BY BLOOD-VESSELS IN RESPONSE TO INJURY [J].

CLARK, RAF ;

QUINN, JH ;

WINN, HJ ;

LANIGAN, JM ;

DELLEPELLA, P ;

COLVIN, RB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (02) :646-651

[10]

CLARKE R. L., 1960, ANGIOLOGY, V11, P367, DOI 10.1177/000331976001100501

← 1 2 3 4 →